| Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment. | |
| | |
MedLine Citation:
|
PMID: 23149444 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVES:: The response rate to treatment of chronic hepatitis C virus-genotype 1 and 4 infections was recently found to be strongly influenced by many polymorphisms. The aim of our study was to carry out an integrated analysis of the effects of polymorphisms and ribavirin (RBV) plasma exposure on outcome. METHODS:: The retrospective analysis included 174 patients. IL28B, CYP27B1, SLC29A1, SLC28A3, and SLC28A2 polymorphisms were genotyped and tested for association with sustained virological response. The impact of RBV plasma exposure during the first 3 months of therapy on outcome was also investigated. RESULTS:: Considering patients infected by hepatitis C virus-1/4, 3 polymorphisms (IL28B rs8099917TT, CYP27B1 rs4646536TT, and CNT2 rs11854484TT) were associated with sustained virological response. The number of negative variant allele and low RBV exposure were correlated to percentage increasing to therapy failure, suggesting some degree of cumulative effect of the 4 factors. A cutoff of 2.5 μg/mL of RBV was found to be associated with outcome (area under ROC [AUROC] curve = 0.64, sensitivity = 55.0%, and specificity = 71.2%, P = 0.020). In multivariate logistic regression analyses, each variant allele and RBV plasma exposure cutoff were independently associated with outcome. CONCLUSIONS:: In this study, we found that additional polymorphisms and RBV plasma exposure are also able to influence the achievement of response. Regardless of the magnitude of RBV pharmacokinetic exposure, the negative predictive value of the polymorphisms here investigated is much stronger than the positive one. |
| | |
Authors:
|
Antonio Dʼavolio; Alessia Ciancio; Marco Siccardi; Antonina Smedile; Marco Simiele; Jessica Cusato; Lorena Baietto; Diego Aguilar Marucco; Giuseppe Cariti; Andrea Calcagno; Daniel Gonzalez de Requena; Mauro Sciandra; Giulia Troshina; Gian Paolo Caviglia; Stefano Bonora; Mario Rizzetto; Giovanni Di Perri |
Related Documents
:
|
15301864 - Polymorphism scan for differences between transmitted and nontransmitted drb1*030101 al... 8911994 - The hla-drb9 gene and the origin of hla-dr haplotypes. 11520344 - Is the decline of desert bighorn sheep from infectious disease the result of low mhc va... 20331784 - Effects of an mhc-drb genotype and allele number on the load of gut parasites in the ba... 9918134 - P53 mutation spectrum in relation to gstm1, cyp1a1 and cyp2e1 in surgically treated pat... 14871374 - Multiple paternity in clutches of common lizard lacerta vivipara: data from microsatell... |
Publication Detail:
|
Type: JOURNAL ARTICLE |
Journal Detail:
|
Title: Therapeutic drug monitoring Volume: 34 ISSN: 1536-3694 ISO Abbreviation: Ther Drug Monit Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-11-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7909660 Medline TA: Ther Drug Monit Country: - |
Other Details:
|
Languages: ENG Pagination: 722-728 Citation Subset: - |
Affiliation:
|
*Unit of Infectious Diseases, University of Turin, Department of Medical Sciences, Amedeo di Savoia Hospital, Turin, Italy †Department of Gastroenterology, S. Giovanni Battista (Molinette) Hospital, Turin, Italy ‡Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The Pharmacokinetic Profile of Intravenous Paracetamol in Adult Patients Undergoing Major Abdominal ...
Next Document: In vivo knockdown of GAD67 in the amygdala disrupts fear extinction and the anxiolytic-like effect o...